SARCOIDOSIS IN ACTUAL CLINICAL PRACTICE
https://doi.org/10.29001/2073-8552-2018-33-3-17-21
Abstract
Heart damage in case of sarcoidosis is associated with high risk of a sudden death; and its verification is very complicated due to lack of pathognomonic symptoms. In this article, we present a review of problems and abilities of cardiac sarcoidosis diagnosis, and main trends of its treatment.
About the Authors
L. G. Evlampieva
Tyumen Cardiology Research Center, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Cand. Sci. (Med.), Junior Scientific Researcher, Laboratory of Instrumental Diagnostics of Scientific Division of Instrumental Research Methods
111, Melnikaite str., Tyumen, 625026, Russian Federation
E. I. Yaroslavskaya
Tyumen Cardiology Research Center, Tomsk National Research Medical Center
Russian Federation
Russian Federation
Dr. Sci. (Med.), Leading Scientific Researcher, Laboratory of Instrumental Diagnostics of Scientific Division of Instrumental Research Methods
111, Melnikaite str., Tyumen, 625026, Russian Federation
References
1. Chuchalin A. G., Avdeev S. N., Aysanov Z. R., Baranova O. P., Borisov S. E., Vizel A. A., Vizel I. Yu., Zaytsev A. A., Ivanova D. A., Lovacheva O. V., Ovsyannikov N. V., Petrov D. V., Romanov V. V., Samsonova M. V., Sivokozov I. V., Solovyova I. P., Stepanian I. E., Tyurin I. E., Cherniayev A. L., Shmelev E. I., Shmeleva N. M. Russian Respiratory Society. Federal guidelines on diagnosis and treatment sarcoidosis. Revision 2016 (In Russ). http://petrsu.ru/files/user/fdbd9903df09bb6f04f397450a13732b (20.12.2016).
2. Stadnikova A. V., Lebed L. V. Sarcoidosis: emergency states. International Medical Journal. 2011; 17(1): 58–62 (In Ukr).
3. Chuchalin A. G., Vizel A. A., Ilkovich M. M. Avdeev S. N., Amirov N. B., Baranova O. P., Borisov S. E., Vizel I. Yu., Lovacheva O. V., Ovsyannikov N. V., Petrov D. V., Romanov V. V., Samsonova M. V., Solovyova I. P., Stepanian I. E., Tyurin I. E., Cherniayev A. L., Shmelev E. I., Shmeleva N. M. Diagnosis and treatment of sarcoidosis: summary of federal conciliative clinical recommendations. Classification, etiopathogenesis, clinic (part I). Bulletin of modern clinical medicine. 2014; 7(4): 62–81 (In Russ). DOI: 10.209691VSKM.2014.7(4).1-82.
4. Yevdokimova S. A., Ponomareva E. V. Sarcoidosis: the state-of-art. A clinical case report of effective treatment of generalized sarcoidosis. Kremlin medicine. Clinical Vestnik Journal. 2017; 4(2): 178–186 (In Russ).
5. Smedema J.-P., van Geuns R.-J., Truter R., Mayosi B. M., Crijns H. J. G. M. Contrast-enhanced cardiac Magnetic Resonance: distinction between cardiac sarcoidosis and infarction scar. Sarcoidosis Vasculitis and Diffuse Lung Diseases Journal. 2017; 34: 307–314.
6. Chuchalin A. G., Vizel A. A., Amirov N. B. Sarcoidosis. Guidance manual for the trainees of the faculties of postgraduate and continuing professional education. Kazan: KGMU; 2010: 58 (In Russ).
7. Borodina G. L. Sarcoidosis. Family Doctor supplement to the Journal of «Health care». 2013; 3: 7–26 (In Beloruss).
8. Terpigorev S. A., El-Zein B. A., Vereshagina V. M., Paleev N. R. Sarcoidosis: problems in classification. Vestnik RAMN. 2012; 67(5): 30–37 (In Russ). DOI: 10.15690/vramn.v67i5.271.
9. Türk Y., Shapiro C.,, Gert-Jan Braunstahl C. A. 15.3. A Marker of disease in sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases Journal. 2017; 34(1): 100–101.
10. Babanov S. A. Sarcoidosis. Russian Medical Journal. 2013; 29: 1500–1504 (In Russ).
11. Yazev E. E., Lebedeva M. V., Strizhakov L. A., Pasha S. P., Mukhin N. A., Sholomova V. I., Brovko M. Yu. Ventricular premature beats as a rare onset of sarcoidosis. Clinical Medicine. 2017; 95(12): 1137–1140 (In Russ). DOI: 10.18821/0023-2149-2017-95-12-1137-1140.
12. Popova E. N., Strizhakov L. A., Sholomova V. I., Ponomarev A. B., Moiseev S. V., Brovko M. Yu., Bondarenko I. B., Ponomareva L. A., Fomin V. V. Clinical features of cardiac lesion in patients with generalized sarcoidosis. Terapevicheskii arkhiv. 2018; 1: 54–59 (In Russ). DOI: 10.17116/terarkh201890154-59.
13. Seward J. B., Casaclang-Verzosa G. Infiltrative cardiovascular diseases. J. Am. Coll. Cardiol. 2010; 55(17): 1769–1779. DOI: 10.1016/j.jacc.2009.12.040.
14. Chapelon-Abric C. Cardiac sarcoidosis. Curr. Opin. Pulm. Med. 2013; 19(5): 493–502.
15. Moiseeva O. M., Mikhailov E. N., Mitrofanova L. B., Khashchevskaya D. A., Ignatieva E. S., Malikov K. N., Ryzhkova D. V. Isolated sarcoidosis of the heart: clinical case and literary review. Russian Journal of Cardiology. 2016; 1(129): 99–104 (In Russ). DOI: 10.15829/1560-4071-2016-1-99-104.
16. Smedena J. P. Tissue Doppler imaging in cardiac sarcoidosis. Eur. J. Echocardiol. 2008; 9(4): 579–580.
17. Baughman R.P., Judson M. A., Wells A.. The indications for the treatment of sarcoidosis: Wells Law. Sarcoidosis Vasculitis and Diffuse Lung Diseases Journal. 2017; 34: 280–282.
18. Youssef G., Leung E., Mylonas I., Neky P., Williams K., Wisenberg G., Gulenchyn K. Y., Dekemp R. A., Dasilva I., Birnie D., Wells G. A., Beanlands R. S. The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience. J. Nucl. Med. 2012; 53(2): 241–248. DOI: 10.2967/jnumed.111.090662.
19. Vizel A. A., Vizel I. Yu. Sarcoidosis: International conciliation documents and recommendations. Russian Medical Journal. 2014; 5: 356–360 (In Russ).
20. Cremers J. P., Drent M., Bast A., Shigemitsu H., Baughman R. P., Valeyre D., Sweiss N. J., Jansen T. L. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr. Opin. Pulm. Med. 2013; 19(5): 545–561. DOI: 10.1097/MCP.0b013e3283642a7a.
21. Sergienko D. V. Sarcoidosis of the respiratory system in clinical practice. Rational pharmacotherapy. 2014; 1(30): 37–42 (In Ukr).
22. Terpigorev S. A., Ilchenko V. A. Prognostic algorithm for disease flow in pulmonary and thoracic lymph nodes sarcoidosis. Almanac of Clinical Medicine. 2014; 35: 42–48 (In Russ). DOI: 10.18786/2072-0505-2014-35-42-48.
23. Vorselaars A. D. M., Verwoerd A., van Moorsel C. H. M., Keijsers R. G. M., Rijkers G. T., Grutters J. C. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur. Respir. J. 2014; 43(2): 602–609. DOI: 10.1183/+09031936,00055213.
Review
For citations:
Evlampieva L.G., Yaroslavskaya E.I. SARCOIDOSIS IN ACTUAL CLINICAL PRACTICE. Siberian Journal of Clinical and Experimental Medicine. 2018;33(3):17-21. (In Russ.) https://doi.org/10.29001/2073-8552-2018-33-3-17-21
Views:
690
.png)
Email this article 